490 stories from 30 sources
The month in Mergers and Acquisitions
Longest running story: 24 days
Click on a headline to see stories that shaped it.
Threads
8 threads
Paramount's proposed Warner Bros. Discovery acquisition moved from financing and closing delays to remedies, settlement talks and litigation. By month's end, the regulatory stalemate had opened the possibility of a breakup or alternative sale of Warner assets.
The Lakers sale reached $12.5 billion, while the Seahawks later sold for $9.6 billion. Together, the transactions established new benchmarks for scarce sports franchises and raised the cost of entry for future buyers.
AstraZeneca's potential $400 billion acquisition of Bristol Myers Squibb began as a test of pharmaceutical scale but ended after investors rejected it. The collapse showed that valuation and strategic concerns could defeat even a megamerger.
Stripe advanced from a reported purchase of OpenRouter above $7 billion to an agreed acquisition valued at as much as $8 billion. The deal would extend Stripe's role from payments into how businesses access, distribute and pay for AI models.
Monte dei Paschi proposed combined bids worth €34 billion for Banco BPM and Banca Generali to avoid becoming an Intesa Sanpaolo takeover target. The plan would create a roughly €70 billion Italian banking group while imposing major financing, regulatory and integration demands.
Goldman Sachs announced acquisitions of Neos and LCN, adding actively managed ETFs, sale-leaseback capabilities and private-market distribution. The transactions showed Goldman using M&A to broaden products and channels rather than relying only on traditional asset management.
Hugging Face moved from exploring a sale near $13 billion to a reported or near-agreed $12.9 billion acquisition by Nvidia. The transaction would give Nvidia greater reach across open-source AI software, models and developers while raising neutrality and antitrust concerns.
Aon neared an agreement to acquire USI from KKR for about $17 billion including debt. The transaction would deepen insurance-brokerage consolidation, but completion and regulatory risks remained ahead.
Week’s Recap